Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$1.34 - $5.34 $844,823 - $3.37 Million
-630,465 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$4.58 - $6.8 $2.89 Million - $4.29 Million
630,465 New
630,465 $2.89 Million

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $85M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Philosophy Capital Management LLC Portfolio

Follow Philosophy Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Philosophy Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Philosophy Capital Management LLC with notifications on news.